FDA label 6986cd5a-854f-18de-e053-2a91aa0a297e
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- 2e3264e8-e167-38a9-e054-00144ff8d46c
- SPL ID
- 6986cd5a-854f-18de-e053-2a91aa0a297e
- Version
- 4
- Effective date
- 2018-04-10
- Source export date
- 2026-09-28
- Source partition
- 10
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:11:05
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | 6986cd5a-854f-18de-e053-2a91aa0a297e | id | |
| spl set id | 2e3264e8-e167-38a9-e054-00144ff8d46c | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings For external use only. Avoid contact with eyes. If symptoms persist for more than seven days, discontinue use and consult physician. Do not apply to wounds or damaged skin. Do not bandage tightly. If pregnant or breast feeding, contact physician prior to use.
warnings and cautions
WARNINGS AND PRECAUTIONS
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS The following serious adverse reactions are discussed in greater detail in other sections: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity Anaphylaxis and Angioedema Withdrawal Precipitated Seizure, Status Epilepticus Suicidal Behavior and Ideation Neuropsychiatric Adverse Reactions (Pediatric Patients 3 to 12 Years of Age) Sudden and Unexplained Death in Patients with Epilepsy 1. Clinical Trials Experience
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.